Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Synaptic, Merck & Co. extend BPH research agreement

Jan. 5, 1998

Cephalon describes new indolocarbazoles for prostate disorders

Dec. 30, 1997

NDA filed for extended-release Ditropan formulation

Dec. 29, 1997

Bladder efficacy demonstrated for KATP channel opener

Dec. 19, 1997

Fujisawa describes preparation of new 5alpha-reductase inhibitor for BPH

Dec. 15, 1997

Sankyo isolates natural products for BPH

Nov. 28, 1997

First launch for Detrusitol

Nov. 21, 1997

Development of tolerance to OPC-31260 effects in rats after chronic treatment

Nov. 17, 1997

OP-1 exhibits protective effects against kidney damage

Nov. 12, 1997

PNU-96293: KATP channel blocker and eukalemic diuretic

Nov. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...